Inventor
Shuwen He
Inventor
Edison, NJ, US
Overview
Patents· 18 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
A61KPreparations for medical, dental or toiletry purposes24%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium6%
Y02ATechnologies for adaptation to climate change6%
PatentTitleYear
11,040,987Penam derivatives for treating bacterial infections202110,538,497Compounds as indoleamine 2,3-dioxygenase inhibitors202010,238,743C5-C6-fused tricyclic iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use201910,071,998Iminothiadiazine dioxides bearing an amine-linked substituent as BACE inhibitors, compositions, and their use20189,868,738'Diazine-fused amidines as BACE inhibitors, compositions, and their use'20189,732,088'C2-carbocyclic iminothiazine dioxides as BACE inhibitors, compositions, and their use'20179,573,939'Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases'20179,549,917'Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases'20179,549,921'Heterocyclic compounds and methods of use thereof for the treatment of hepatitis C'20179,493,461'Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C'20169,364,482'Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases'20169,265,773'Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases'20169,242,998'Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C'20169,243,002'Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C'20168,754,099'Oxadiazole beta carboline derivatives as antidiabetic compounds'20148,183,275'Substituted imidazoles as bombesin receptor subtype-3 modulators'20127,652,024'Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators'20107,329,673'Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists'2008Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2008–2019Based in Edison, NJ, US· patent location history
2010–2020Patents assigned to MERCK SHARP & DOHME (16)· patent assignee history
2012–2019Patents assigned to HE SHUWEN (9)· patent assignee history
2014–2017Patents assigned to LAI ZHONG (5)· patent assignee history
2016–2017Patents assigned to DAI XING (5)· patent assignee history
2016–2017Patents assigned to LI PENG (5)· patent assignee history
2016–2020Based in Fanwood, NJ, US· patent location history
2021Based in Suzhou, CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK SHARP & DOHME | 16 | 2010–2020 |
| HE SHUWENself | 9 | 2012–2019 |
| DAI XING | 5 | 2016–2017 |
| LAI ZHONG | 5 | 2014–2017 |
| LI PENG | 5 | 2016–2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| Edison, New Jersey, US | 9 | 2008–2019 |
| Fanwood, New Jersey, US | 8 | 2016–2020 |
| Suzhou, CN | 1 | 2021 |